MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walkme Ltd (NQ: WKME )

13.95 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walkme Ltd

< Previous 1 2 3 4 5 Next >
WalkMe to Present at Upcoming Investor Conference
From WalkMe Inc.
Via GlobeNewswire
WalkMe: Q1 Earnings Insights
Via Benzinga
WalkMe Ltd. Announces First Quarter 2023 Financial Results
From WalkMe Inc.
Via GlobeNewswire
WalkMe's Earnings: A Preview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
Via Benzinga
Expert Ratings for WalkMe
Via Benzinga
Analyst Ratings for WalkMe
Via Benzinga
Warner Bros. Discovery To Rally Around 62%? Here Are 10 Other Analyst Forecasts For Monday
Wells Fargo raised the price target for Stanley Black & Decker, Inc. (NYSE: SWK) from $85 to $90. Wells Fargo analyst Joe O'Dea maintained an Equal-Weight rating. Stanley Black & Decker shares rose 3%... 
Via Benzinga
CORRECTION: WalkMe Announces Date of First Quarter 2023 Financial Results and Conference Call
From WalkMe Inc.
Via GlobeNewswire
WalkMe Unveils the Latest in the Evolution of Digital Adoption Technology With WalkMe Discovery
WalkMe Discovery helps enterprises unlock the hidden value of their tech stack by providing visibility into what software is running, who is using it, and how it’s being used 
From WalkMe Inc.
Via GlobeNewswire
5 Analysts Have This to Say About WalkMe
Via Benzinga
WalkMe's Focus On Enterprise Customer Will Drive Profitability, Analyst Says
Via Benzinga
Expert Ratings for WalkMe
Via Benzinga
Analyst Ratings for WalkMe
Via Benzinga
WalkMe Announces Date of First Quarter 2023 Financial Results and Conference Call
From WalkMe Inc.
Via GlobeNewswire
WalkMe's Second Downsizing Of 2023: Analyst Expects Improved Operating Margins, Long-Term Growth
Needham analyst Scott Berg reiterates WalkMe Ltd (NASDAQ: WKME) with a Buy  
Via Benzinga
WalkMe Achieves FedRAMP® Ready Status
Milestone demonstrates WalkMe’s continued commitment to the U.S. Public Sector Market 
From WalkMe Inc.
Via GlobeNewswire
WalkMe Confirms No Material Exposure to Silicon Valley Bank Shutdown
From WalkMe LTD.
Via GlobeNewswire
WalkMe to Present at Upcoming Investor Conferences
From WalkMe LTD.
Via GlobeNewswire
WalkMe Ltd. Appoints Hagit Ynon as Chief Financial Officer
Former Interim CFO and EVP of Finance & Operations to assume permanent CFO role 
From WalkMe LTD.
Via GlobeNewswire
WalkMe Announces Date of Fourth Quarter and Full Year 2022 Financial Results and Conference Call
From WalkMe LTD.
Via GlobeNewswire
WalkMe Announces Leadership and Board Changes
WalkMe co-founder Rafael Sweary to step down as President; Board Member Michele Bettencourt appointed as Board Chairperson 
From WalkMe LTD.
Via GlobeNewswire
WalkMe to Present at Upcoming Investor Conferences
From WalkMe LTD.
Via GlobeNewswire
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
WalkMe Announces Date of Third Quarter 2022 Financial Results and Conference Call
From WalkMe LTD.
Via GlobeNewswire
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story